Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma

Christopher S. Koivisto, Melodie Parrish, Santosh B. Bonala, Soo Ngoi, Adrian Torres, James Gallagher, Rebekah Sanchez-Hodge, Victor Zeinner, Georges J. Nahhas, Bei Liu, David E. Cohn, Floor J. Backes, Paul J. Goodfellow, Helen M. Chamberlin, Gustavo Leone

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)484-496
Number of pages13
JournalNeoplasia (United States)
Volume22
Issue number10
DOIs
StatePublished - Oct 2020
Externally publishedYes

ASJC Scopus Subject Areas

  • Cancer Research

Keywords

  • Androgen receptor antagonist
  • Endometrial carcinoma
  • Enzalutamide
  • Mouse model of endometrial cancer
  • PTEN
  • Preclinical drug evaluation

Cite this